Design Therapeutics
  • About Us
  • Our Approach
  • Our Programs
    • Overview
    • Friedreich Ataxia Program
    • Fuchs Endothelial Corneal Dystrophy Program
    • Myotonic Dystrophy Program
    • Huntington’s Disease Program
    • Research Programs
  • Patients
    • Friedreich Ataxia
    • Expanded Access Programs
  • Investors
    • Home
    • News & Events
      • News Releases
      • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
    • Corporate Governance
      • Documents & Charters
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Investor Resources
      • FAQs
      • Email Alerts
      • Contact IR
  • Careers

Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders

Design Therapeutics
Design Therapeutics

6005 Hidden Valley Road
Suite 110
Carlsbad, CA 92011
858-293-4900

Investors & Media

renee@thrustsc.com

Careers

work@designtx.com

General

info@designtx.com

© 2025 Design Therapeutics, Inc. All Rights Reserved. | Privacy Policy | Terms of Use